Neurological Complications of Neurofibromatosis Type 1 in Adulthood
Brain 122:473-481, Creange,A.,et al, 1999

Magnetic Resonance Imaging Results of the PRISMS Trial:A Randomized, Double-Blind, Placebo-Controlled Study of Interferon-B1a in Relapsing-Remitting Multiple Scleroosis
Ann Neurol 46:197-206, Li,D.K.B.,et al, 1999

Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999

Highly Active Antiretroviral Therapy Reverses Brain Metabolite Abnormalities in Mild HIV Dementia
Neurol 53:782-789, Chang,L.,et al, 1999

Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis and Future Directions for Multiple Sclerosis Therapeutics
Arch Neurol 56:1079-1084, Rudick,R.A., 1999

Treatment Recommendations for Interferon-B in Multiple Sclerosis
JNNP 67:561-566, Polman,C.H.,et al, 1999

Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999

Interferon-B-1a in Relapsing-Remitting Multiple Sclerosis:Effect on Hypointense Lesion Volume on T1 Weighted Images
JNNP 67:579-584, Gasperini,C.,et al, 1999

MR Findings in AIDS-Associated Myelopathy
AJNR 20:1412-1416,1387, Chong,J.,et al, 1999

Brain Biopsy in Patients with Acquired Immunodeficiency Syndrome, Diagnostic Value, Clinical Performance, and Survival Time
Arch Int Med 159:2590-2596, Hornef,M.W.,et al, 1999

Cryptococcus Meningoencephalitis in AIDS:Parenchymal and Meningeal Forms
Neuroradiology 41:129-133, Berkefeld,J.,et al, 1999

Epstein-Barr Virus in Monitoring the Response to Therapy of Acquired Immunodeficiency-Related Primary Central Nervous System Lymphoma
Ann Neurol 5:259-261, Antinori,A.,et al, 1999

Value of Combined Approach with Thallium-201 Single-Proton Emission Computed Tomography and Epstein-Barr Virus DNA Polymerase Chain Reaction in CSF for the Diagnosis of AIDS-Related Primary CNS Lympho
J Clin Oncol 17:554-560, Antinori,A.,et al, 1999

Isolated,Chronic,Epilepsia Partialis Continua in an HIV-Infected Patient
Arch Neurol 56:111-114, Bartolomei,F.,et al, 1999

Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999

Severe Anaphylaxis with Recombinant Interferon Beta
Neurol 52:425, Corona,T.,et al, 1999

Progressive Multifocal Leukoencephalopathy and Human Immunodeficiency Virus-associated White Matter Lesions in AIDS:Magnetization Transfer MR Imaging
Radiology 210:539-543, Ernst,T.,et al,, 1999

Radiation-Induced Cerebral Vasculopathy in Children with Neurofibromatosis and Optic Pathway Glioma
Ann Neurol 45:393-396, Grill,J.,et al, 1999

Herpes Varicella Zoster Encephalitis in Immunocompromised Patients
Neurol 52:193-195, Weaver,S.,et al, 1999

Cerebral Tumor-Like American Trypanosomiasis in Acquired Immunodeficiency Syndrome
Ann Neurol 45:403-406, Pagano,M.A.,et al, 1999

HAART Improves Prognosis in HIV-Associated Progressive Multifocal Leukoencephalopathy
Neurol 52:623-625,440, Clifford,D.B.,et al, 1999

Multiple Sclerosis,Therapeutic Update
Arch Neurol 56:277-280, Tselis,A.C.&Lisak,R.P., 1999

Neuropsychological Status in Multiple Sclerosis after Treatment with Glatiramer
Arch Neurol 56:319-324, Weinstein,A.,et al, 1999

Paroxysmal Dyskinesias in Patients with HIV Infection
Neurol 52:109-114, Mirsattari,S.M.,et al, 1999

Lipodystrophy Associated with an HIV-Protease Inhibitor
NEJM 339:1296, Carr,A.&Cooper,D.A., 1998

Buffalo Hump in a Patient with the Acquired Immunodeficiency Syndrome
NEJM 339:1297, Aboulafia,D.M.&Bundow,D., 1998

Incidence of Dilated Cardiomyopathy and Detection of HIV in Myocardial Cells of HIV-Positive Patients
NEJM 339:1093-1099,1153, Barbaro,G.,et al, 1998

A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998

Evaluation and Management of Intracranial Mass Lesions in AIDS
Rpt of Quality Stnds Subcomm of the AAN, Neurol 50:21-261998., , 1998

Human Herpesvirus 8 DNA in CNS Lymphomas from Patients With and Without AIDS
Neurol 50:335-340, 3221998., Corboy,J.R.,et al, 1998

Central Nervous System Infection with Listeria Monocytogenes
Medicine 77:313-316, Mylonakis,E.,et al, 1998

Neutralizing Antibodies to Interferon B-1a and Interferon B-1b in MS Patients are Cross-Reactive
Neurol 51:1698-1702, Khan,O.A. & Dhib-Jalbut,S., 1998

Low-Dose Steroids Reduce Flu-Like Symptoms at the Initiation of INFB-1b in Relapsing-Remitting MS
Neurol 50:1910-1912, Rio,J.,et al, 1998

Incidence and Significance of Neutralizing Antibodies to Interferon Beta-1a in Multiple Sclerosis
Neurol 50:1266-1272, 12061998., Rudick,R.A.,et al, 1998

Acute Leukoencephalopathies:Differential Diagnosis and Investigation
The Neurologist 4:148-166, Weinshenker,B.G.,et al, 1998

Failure of Cytarabine in Progressive Multifocal Leukoencephalopathy Associated with Human Immunodeficiency Virus Infection
NEJM 338:1345-1351, 13781998., , 1998

Mass Effect in Progressive Multifocal Leukoencephalopathy
Arch Neurol 55:1148-1149, Finelli,P.F., 1998

Herpes Zoster Ophthalmicus in Patients with Human Immunodeficiency Virus Infection
Am J Ophthalmol 125:285-291, Margolis,T.P.,et al, 1998

Thallium-201 Brain SPECT of Lymphoma in AIDS Patients:Pitfalls and Technique Optimization
AJNR 19:1105-1109, Kessler,L.S.,et al, 1998

Clinical Usefulness of Magnetic Resonance Imaging in Multiple System Atrophy
JNNP 65:65-71, Schrag,A.,et al, 1998

Progressive Multifocal Leukoencephalopathy, HIV, and Highly Active Antiretroviral Therapy
NEJM 339:848-849, Cinque,P.,et al, 1998

Predictive Factors for Prolonged Survival in AIDS-Associated PML
Ann Neurol 44:341-349, Berger,J.R.,et al, 1998

Recombinant Human Nerve Growth Factor in the Treatment of Diabetic Polyneuropathy
Neurol 51:695-702, 6621998., Apfel,S.C.,et al, 1998

Incidence of Dominant Spinocerebellar and Friedreich Triplet Repeats Among 361 Ataxic Families
Neurol 51:1666-1671, Moseley,M.L.,et al, 1998

Interferon B Therapy for Multiple Sclerosis
Lancet 352:1486-1487, Goodkin,D.E., 1998

Interferons in the Treatment of Multiple Sclerosis,Do They Prevent the Progression of the Disease?
Arch Neurol 55:1578-1580,1583, Rice,G.&Ebers,G, 1998

Interferons Should be Used to Treat Most Patients with MS
Arch Neurol 55:1581-1583, Herndon,R.M.&Jacobs,L, 1998

Randomised Double-Blind Placebo-Controlled Study of Interferon B-1a in Relapsing/Remitting Multiple Sclerosis
Lancet 352:1498-1504,1486, PRISMS, 1998

Placebo-Controlled Multicentre Randomised Trial of Interferon B-1b in Treatment of Secondary Progressive Multiple Sclerosis
Lancet 352:1491-1497,1486, European Study Group on Interferon B-1b in Seconda, 1998

Extended Use of Glatiramer Acetate (Copaxone) Is Well Tol & Maint Its Clin Effect on MS Relapse Rate & Degree of Disabil
Neurol 50:701-708, Johnson,K.P.,et al, 1998